Leap Investments’s Assembly Biosciences ASMB Stock Holding History

Leap Investments’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,208	Closed	-$196K	–	403
2019 Q2	$196K	Buy	+1,208	New	+$230K	0.26%	158

Other funds holding ASMB

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Leap Investments's ASMB Position: Q3 2019 in Review

Leap Investments sold out of Assembly Biosciences (ASMB) in Q3 2019, closing a stake of 1,208 shares — an estimated $196K sold.

Leap Investments first reported a position in ASMB in Q2 2019 and held it in 1 quarter. The position peaked at $196K in Q2 2019. 98 funds tracked by Wall St. Rank hold ASMB as of Q3 2019.

Leap Investments reported no remaining Assembly Biosciences position as of Q3 2019 after selling out during the quarter.
Leap Investments sold 1,208 Assembly Biosciences shares in Q3 2019, an estimated $196K.
Leap Investments first reported a position in Assembly Biosciences in Q2 2019 and held it in 1 quarter.
Leap Investments's Assembly Biosciences position peaked at $196K in Q2 2019.
98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.